GeneFx Lung diagnostic data

A validation study analyzing 181 frozen, resected stage I/II NSCLC tumor specimens showed that Med BioGene's GeneFx Lung classified the samples into

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE